Clinical Trials
4 trialsNCT05625399 2026-06-03
RELATIVITY-127
Bristol-Myers Squibb
Phase 3 Active not recruiting
NCT06743126 2026-05-29
SUPRAME
Immatics US, Inc.
Phase 3 Recruiting
NCT06246916 2026-05-06
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Regeneron Pharmaceuticals
Phase 3 Recruiting
NCT05002569 2026-01-08
RELATIVITY-098
Bristol-Myers Squibb
Phase 3 Terminated